Patent application number | Description | Published |
20100064306 | METHOD AND SYSTEM FOR BROADCASTING MEDIA CONTENT BASED ON USER INPUT - Methods and systems enable mobile TV providers to select programs for broadcast based on viewer preference indications or votes. Information regarding candidate programs or content may be broadcast and displayed on mobile devices. A voting user interface may receive viewer preferences or votes and transmit vote information to the mobile TV broadcast network using a unicast network. Received voting information may be tallied to select a program or content for broadcast. Interim vote tallies may be broadcast to mobile devices until a voting session is terminated. Results of the voting session may be broadcasted followed by broadcast of the selected program. | 03-11-2010 |
20110177774 | DYNAMIC GENERATION, DELIVERY, AND EXECUTION OF INTERACTIVE APPLICATIONS OVER A MOBILE BROADCAST NETWORK - Systems, apparatus and methods provide an automatic capability for generating interactivity event applications for execution on receiver devices within a broadcast network based upon interactivity event application data, information and sequence logic. Interactivity event content providers may provide to a broadcast network interactivity event application data, event metadata information and sequence logic a broadcast network. Such applications may be transmitted via the broadcast network. Transmitted applications may be activated in receiver devices in response to receiving a signal from a real-time broadcast stream. Activation signals may be used to synchronize application activation with an event in a media program so downloaded applications may be activated in synchrony with broadcast programs. Interactive applications may be dynamically generated at run time. Multiple interactive applications may be generated from a same set of interactivity application data, each targeting different types of devices. Signaling mechanisms may signal multiple return unicast channels for user responses. | 07-21-2011 |
20120280902 | PROXIMITY SENSOR MESH FOR MOTION CAPTURE - Apparatuses for motion capture are disclosed that includes a surface configured to support an object; and at least one sensor arranged with the surface, wherein the at least one sensor is configured to communicate with one or more remote sensors to obtain at least one of ranging or inertial information for use in a kinematic model of the object. A method for motion capture is also disclosed that includes providing a surface configured to support an object; and arranging at least one sensor with the surface, wherein the at least one sensor is configured to communicate with one or more remote sensor to obtain at least one ranging or inertial information for use in a kinematic model of the object. | 11-08-2012 |
20120283016 | METHOD AND APPARATUS OF PROXIMITY AND STUNT RECORDING FOR OUTDOOR GAMING - Apparatuses for motion capture are disclosed that includes a surface configured to support an object; and at least one sensor arranged with the surface, wherein the at least one sensor is configured to obtain at least one of ranging or inertial information for use in estimating a motion of the surface with respect to the object. A method for motion capture is also disclosed that includes providing a surface configured to support an object; and obtaining at least one of ranging or inertial information for use in estimating a motion of the surface with respect to the object via at least one sensor. | 11-08-2012 |
20120283896 | GESTURE RECOGNITION VIA AN AD-HOC PROXIMITY SENSOR MESH FOR REMOTELY CONTROLLING OBJECTS - Apparatuses for remote operation of a first object by a second object is disclosed that one or more sensors configured to be placed on the second object and to obtain ranging information; and a processing system configured to determine one or more movements of the second object from the ranging information; and generate one or more control signals related to the one or more movements for manipulating the first object. | 11-08-2012 |
20120293630 | METHOD AND APPARATUS FOR MULTI-CAMERA MOTION CAPTURE ENHANCEMENT USING PROXIMITY SENSORS - Apparatuses for image capture are disclosed that includes an image sensor; and one or more sensors configured to determine ranging information between the image sensor and a remote image sensor. Apparatuses for imaging are disclosed that includes a receiver configured to receive ranging information and captured images from a plurality of devices; and a processing system configured to generate three-dimensional images from the ranging information and the captured images. | 11-22-2012 |
20120296453 | METHOD AND APPARATUS FOR USING PROXIMITY SENSING FOR AUGMENTED REALITY GAMING - Apparatuses for wireless communication is disclosed that includes a receiver configured to receive ranging information from at least one of one or more sensors arranged with an object and one or more sensors remote from the object; and a processing system configured to track the object with respect to the one or more sensors remote from the object based on the ranging information. A method for wireless communication is disclosed that includes receiving ranging information from at least one of one or more sensors arranged with an object and one or more sensors remote from the object; and tracking the object with respect to the one or more sensors remote from the object based on the ranging information. | 11-22-2012 |
20120302129 | METHOD AND APPARATUS FOR REMOTE CONTROLLED OBJECT GAMING WITH PROXIMITY-BASED AUGMENTED REALITY ENHANCEMENT - Apparatuses for remote control by a remote object is disclosed that includes one or more sensors configured to communicate with the remote object to obtain ranging information of the apparatus relative to the remote object; and a processing system configured to provide local control of the apparatus based on the ranging information. | 11-29-2012 |
Patent application number | Description | Published |
20120273342 | COMPACT ION ACCELERATOR SOURCE - An ion source includes a conductive substrate, the substrate including a plurality of conductive nanostructures with free-standing tips formed on the substrate. A conductive catalytic coating is formed on the nanostructures and substrate for dissociation of a molecular species into an atomic species, the molecular species being brought in contact with the catalytic coating. A target electrode placed apart from the substrate, the target electrode being biased relative to the substrate with a first bias voltage to ionize the atomic species in proximity to the free-standing tips and attract the ionized atomic species from the substrate in the direction of the target electrode. | 11-01-2012 |
20130044846 | COMPACT ION SOURCE NEUTRON GENERATOR - A neutron generator includes a conductive substrate comprising a plurality of conductive nanostructures with free-standing tips and a source of an atomic species to introduce the atomic species in proximity to the free-standing tips. A target placed apart from the substrate is voltage biased relative to the substrate to ionize and accelerate the ionized atomic species toward the target. The target includes an element capable of a nuclear fusion reaction with the ionized atomic species to produce a one or more neutrons as a reaction by-product. | 02-21-2013 |
20140070701 | ADVANCED PENNING ION SOURCE - This disclosure provides systems, methods, and apparatus for ion generation. In one aspect, an apparatus includes an anode, a first cathode, a second cathode, and a plurality of cusp magnets. The anode has a first open end and a second open end. The first cathode is associated with the first open end of the anode. The second cathode is associated with the second open end of the anode. The anode, the first cathode, and the second cathode define a chamber. The second cathode has an open region configured for the passage of ions from the chamber. Each cusp magnet of the plurality of cusp magnets is disposed along a length of the anode. | 03-13-2014 |
Patent application number | Description | Published |
20080233183 | TOPICAL FORMULATIONS HAVING ENHANCED BIOAVAILABILITY - The present disclosure provides compositions suitable for delivering lipophilic bioactive agents. The compositions may be utilized to treat numerous diseases and conditions that would benefit from the application of a lipophilic bioactive agent. | 09-25-2008 |
20080299100 | Topical Co-Enzyme Q10 Formulations and Methods of Use - Topical formulations of CoQ10 reduce the rate of tumor growth in an animal subject. In the experiments described herein, CoQ10 was shown to increase the rate of apoptosis in a culture of skin cancer cells but not normal cells. Moreover, treatment of tumor-bearing animals with a topical formulation of CoQ10 was shown to dramatically reduce the rate of tumor growth in the animals. | 12-04-2008 |
20100062048 | TOPICAL CO-ENZYME Q10 FORMULATIONS AND TREATMENT OF PAIN, FATIGUE AND WOUNDS - CoQ1O has a stimulatory effect on fibroblasts and keratinocytes, increases ATP production, decreases pain. The formulations are useful for promoting acute wound healing, fatigue and treatment of acute and chronic pain. | 03-11-2010 |
20110027811 | ASSAY SYSTEM FOR THE ASSESSMENT OF ONCOGENICITY, TUMOR PROGRESSION, AND TREATMENT EFFICACY - Systems and kits are provided which are capable of determining the oncogenicity of a cancer, tumor progression, and effectiveness of a cancer treatment. Such systems and kits utilize assays to examine the levels of apoptotic markers, angiogenesis markers, immunomodulation markers, and cell cycle markers and can compare samples from a patient taken at different times to determine the oncogenicity of a cancer, tumor progression, and effectiveness of a cancer treatment. Methods for determining the oncogenicity of a cancer, tumor progression, and effectiveness of a cancer treatment with such systems and kits are also provided. | 02-03-2011 |
20110136231 | METHODS AND USE OF INDUCING APOPTOSIS IN CANCER CELLS - The present disclosure relates to a method of inducing apoptosis in a cancer cell by delivery of exogenous Coenzyme Q1O or its metabolites thereof in a pharmaceutically acceptable carrier to effectuate cell contact of endogenous Coenzyme Q1O or its metabolites thereof in addition to but not limited to mevalonic acid and oleic acid to form an intracellular complex. The present disclosure also provides a method of modulating the p53 pathway and Bcl-2 protein family in a manner that restores the apoptotic potential to a cancer cell by delivery of Coenzyme Q1O in a pharmaceutically acceptable carrier. The present disclosure further provides a method to specifically normalize the ratio of pro-apoptotic and anti-apoptotic members of the Bcl-2 gene family in a proportion to re-program a cancer cell to undergo apoptosis. | 06-09-2011 |
20110142914 | INHALABLE COMPOSITIONS HAVING ENHANCED BIOAVAILABILITY - The present disclosure provides methods and compositions suitable for delivering lipophilic bioactive agents. The compositions may be utilized to treat numerous diseases and conditions that would benefit from the application of a lipophilic bioactive agent. In embodiments the compositions may be introduced by inhalation. | 06-16-2011 |
20120164215 | TOPICAL CO-ENZYME Q10 FORMULATIONS AND METHODS OF USE - Topical formulations of CoQ10 reduce the rate of tumor growth in an animal subject. In the experiments described herein, CoQ10 was shown to increase the rate of apoptosis in a culture of skin cancer cells but not normal cells. Moreover, treatment of tumor-bearing animals with a topical formulation of CoQ10 was shown to dramatically reduce the rate of tumor growth in the animals. | 06-28-2012 |
20120201801 | TOPICAL CO-ENZYME Q10 FORMULATIONS AND METHODS OF USE - Topical formulations of CoQ10 reduce the rate of tumor growth in an animal subject. In the experiments described herein, CoQ10 was shown to increase the rate of apoptosis in a culture of skin cancer cells but not normal cells. Moreover, treatment of tumor-bearing animals with a topical formulation of CoQ10 was shown to dramatically reduce the rate of tumor growth in the animals. | 08-09-2012 |
20120309086 | METHODS AND USE OF INDUCING APOPTOSIS IN CANCER CELLS - The present disclosure relates to a method of inducing apoptosis in a cancer cell by delivery of exogenous Coenzyme Q10 or its metabolites thereof in a pharmaceutically acceptable carrier to effectuate cell contact of endogenous Coenzyme Q10 or its metabolites thereof in addition to but not limited to mevalonic acid and oleic acid to form an intracellular complex. The present disclosure also provides a method of modulating the p53 pathway and Bcl-2 protein family in a manner that restores the apoptotic potential to a cancer cell by delivery of Coenzyme Q10 in a pharmaceutically acceptable carrier. The present disclosure further provides a method to specifically normalize the ratio of pro-apoptotic and anti-apoptotic members of the Bcl-2 gene family in a proportion to re-program a cancer cell to undergo apoptosis. | 12-06-2012 |
20130189237 | CO-ENZYME Q10 FORMULATIONS AND METHODS OF USE - Topical formulations of CoQ10 reduce the rate of tumor growth in an animal subject. In the experiments described herein, CoQ10 was shown to increase the rate of apoptosis in a culture of skin cancer cells but not normal cells. Moreover, treatment of tumor-bearing animals with a topical formulation of CoQ10 was shown to dramatically reduce the rate of tumor growth in the animals. | 07-25-2013 |
20130202683 | TOPICAL FORMULATIONS HAVING ENHANCED BIOAVAILABILITY - The present disclosure provides compositions suitable for delivering lipophilic bioactive agents. The compositions may be utilized to treat numerous diseases and conditions that would benefit from the application of a lipophilic bioactive agent. | 08-08-2013 |
20140023627 | TOPICAL CO-ENZYME Q10 FORMULATIONS AND METHODS OF USE - Topical formulations of CoQ10 reduce the rate of tumor growth in an animcal subject. In the experiments described herein, CoQ10 was shown to increase the rate of apoptosis in a culture of skin cancer cells but not normal cells. Moreover, treatment of tumor-bearing animals with a topical formulation of CoQ10 was shown to dramatically reduce the rate of tumor growth in the animals. | 01-23-2014 |
20140255372 | CO-ENZYME Q10 FORMULATIONS AND METHODS OF USE - Topical formulations of CoQ10 reduce the rate of tumor growth in an animal subject. In the experiments described herein, CoQ10 was shown to increase the rate of apoptosis in a culture of skin cancer cells but not normal cells. Moreover, treatment of tumor-bearing animals with a topical formulation of CoQ10 was shown to dramatically reduce the rate of tumor growth in the animals. | 09-11-2014 |
20150010614 | METHODS AND USE OF INDUCING APOPTOSIS IN CANCER CELLS - The present disclosure relates to a method of inducing apoptosis in a cancer cell by delivery of exogenous Coenzyme Q1O or its metabolites thereof in a pharmaceutically acceptable carrier to effectuate cell contact of endogenous Coenzyme Q1O or its metabolites thereof in addition to but not limited to mevalonic acid and oleic add to form an intracellular complex. The present disclosure also provides a method of modulating the p53 pathway and Bcl-2 protein family in a manner that restores the apoptotic potential to a cancer cell by delivery of Coenzyme Q1O in a pharmaceutically acceptable carrier. The present disclosure further provides a method to specifically normalize the ratio of pro-apoptotic and anti-apopotic members of the Bcl-2 gene family in a proportion to re-program a cancer cell to undergo apoptosis. | 01-08-2015 |
20150231091 | METHODS AND USE OF INDUCING APOPTOSIS IN CANCER CELLS - The present disclosure relates to a method of inducing apoptosis in a cancer cell by delivery of exogenous Coenzyme Q10 or its metabolites thereof in a pharmaceutically acceptable carrier to effectuate cell contact of endogenous Coenzyme Q10 or its metabolites thereof in addition to but not limited to mevalonic acid and oleic acid to form an intracellular complex. The present disclosure also provides a method of modulating the p53 pathway and Bcl-2 protein family in a manner that restores the apoptotic potential to a cancer cell by delivery of Coenzyme Q10 in a pharmaceutically acceptable carrier. The present disclosure further provides a method to specifically normalize the ratio of pro-apoptotic and anti-apoptotic members of the Bcl-2 gene family in a proportion to re-program a cancer cell to undergo apoptosis. | 08-20-2015 |